Lack of a pharmacokinetic interaction between azithromycin and chloroquine

被引:33
作者
Cook, JA [1 ]
Randinitis, EJ [1 ]
Bramson, CR [1 ]
Wesche, DL [1 ]
机构
[1] Pfizer Inc, Global Res & Dev, Michigan Labs, Ann Arbor, MI 48105 USA
关键词
D O I
10.4269/ajtmh.2006.74.407
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A study was conducted to investigate a possible pharmacokinetic interaction between azithromycin and chloroquine. Twenty-four subjects received azithromycin, 1,000 mg a day for three days, followed by a washout period, then azithromycin, 1 000 mg plus chloroquine 600 mg base on days I and 2, and azithromycin, 1,000 mg plus chloroquine 300 mg base oil day 3 of the final period. A second group of 16 subjects received chloroquine, 600 mg base oil days I and 2, then 300 mg base on day 3. Blood samples were obtained serially up to 624 hours after the day 3 dose in each period. Log transformed maximum concentration and area under the curve values of azithromycin and chloroquine were compared using 90% confidence intervals calculated from appropriate analysis of variance models. Ninety percent confidence intervals for all pharmacokinetic parameters were contained within the interval 80-125%, which indicates the absence of a clinically relevant pharmacokinetic interaction.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 13 条
[1]   PROPHYLAXIS OF PLASMODIUM-FALCIPARUM MALARIA WITH AZITHROMYCIN ADMINISTERED TO VOLUNTEERS [J].
ANDERSON, SL ;
BERMAN, J ;
KUSCHNER, R ;
WESCHE, D ;
MAGILL, A ;
WELLDE, B ;
SCHNEIDER, I ;
DUNNE, M ;
SCHUSTER, BG .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (10) :771-773
[2]  
AUGUSTIJNS P, 1992, EUR J CLIN PHARMACOL, V42, P429
[3]  
Biswas S, 2001, J Postgrad Med, V47, P240
[4]   RELATIONSHIP OF GLOBAL CHLOROQUINE TRANSPORT AND REVERSAL OF RESISTANCE IN PLASMODIUM-FALCIPARUM [J].
BRAY, PG ;
BOULTER, MK ;
RITCHIE, GY ;
HOWELLS, RE ;
WARD, SA .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 63 (01) :87-94
[5]   A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India [J].
Dunne, MW ;
Singh, N ;
Shukla, M ;
Valecha, N ;
Bhattacharyya, PC ;
Dev, V ;
Patel, K ;
Mohapatra, MK ;
Lakhani, J ;
Benner, R ;
Lele, C ;
Patki, K .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (10) :1582-1588
[6]   THE SINGLE DOSE KINETICS OF CHLOROQUINE AND ITS MAJOR METABOLITE DESETHYLCHLOROQUINE IN HEALTHY-SUBJECTS [J].
FRISKHOLMBERG, M ;
BERGQVIST, Y ;
TERMOND, E ;
DOMEIJNYBERG, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (04) :521-530
[7]   Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda [J].
Gray, RH ;
Wabwire-Mangen, F ;
Kigozi, G ;
Sewankambo, NK ;
Serwadda, D ;
Moulton, LH ;
Quinn, TC ;
O'Brien, KL ;
Meehan, M ;
Abramowsky, C ;
Robb, M ;
Wawer, MJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (05) :1209-1217
[8]   DISPOSITION OF CHLOROQUINE IN MAN AFTER SINGLE INTRAVENOUS AND ORAL DOSES [J].
GUSTAFSSON, LL ;
WALKER, O ;
ALVAN, G ;
BEERMANN, B ;
ESTEVEZ, F ;
GLEISNER, L ;
LINDSTROM, B ;
SJOQVIST, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (04) :471-479
[9]  
KOUZNETSOV RL, 1996, MALARIA MANUAL COMMU, P31
[10]   PROTEIN-BINDING OF CHLOROQUINE ENANTIOMERS AND DESETHYLCHLOROQUINE [J].
OFORIADJEI, D ;
ERICSSON, O ;
LINDSTROM, B ;
SJOQVIST, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (03) :356-358